BFLY vs HTFL vs QDEL Stock Comparison

Butterfly Network, Heartflow and QuidelOrtho Prices as of Nov 3, 2026 Peers: Industry group
1 more company in this comparison (LNTH) Create a free account to keep reading and compare up to 10 companies.
BFLY Butterfly Network, Inc.
$6.40 -28.3% 1M +119.9% 1Y
Market cap
$1.78B
P/E
–
Revenue (TTM)
$123.25M
Div. yield
–
Diagnostic Equipment Healthcare
4 wins
HTFL Heartflow, Inc.
$54.40 +10.3% 1M +59.8% 1Y
Market cap
$4.90B
P/E
–
Revenue (TTM)
$212.08M
Div. yield
–
Diagnostic Equipment Healthcare
3 wins
QDEL QuidelOrtho Corp
$14.09 +30.8% 1M -49.2% 1Y
Market cap
$970.54M
P/E
–
Revenue (TTM)
-$211.90M
Div. yield
–
Diagnostic Equipment Healthcare

Head to Head

7 decided of 12

Butterfly Network leads on 4 of the 12 questions below (Butterfly Network 4, Heartflow 3). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionBFLYHTFLQDELLeader
Larger companyMarket capitalisation $1.78B $4.90B $970.54M HTFL
Cheaper on earningsLower P/E, profitable companies only -33.2x -41.4x -0.9x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS — — 18.8x –
Faster revenue growthRevenue growth, trailing twelve months +39.4% +42.8% -30.8% HTFL
More profitableNet margin, trailing twelve months -43.6% -55.8% — BFLY
Better return on capitalReturn on invested capital — — — –
Less leveragedLower net debt / EBITDA — — — –
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +119.9% +59.8% -49.2% BFLY
Better 5-year returnAnnualised price return, 5 years -9.4%/yr — -36.5%/yr BFLY
Less volatileAnnualised volatility, 1 year 112.7% 76.7% 93.2% HTFL
Higher overall scoreMean of the five percentile scores vs peers 50/100 49/100 23/100 BFLY

Percentile Scorecard

BFLYHTFLQDEL

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisBFLYHTFLQDEL
Valuation 29 #164 of 229 27 #167 of 229 46 #124 of 229
Growth 90 #24 of 221 73 #61 of 221 1 #219 of 221
Profitability 38 #130 of 209 42 #121 of 209 –
Financial Health 57 #103 of 240 84 #39 of 240 11 #215 of 240
Shareholder Returns 36 #95 of 147 19 #119 of 147 35 #96 of 147
Overall 50 49 23
  • BFLY ranked among 248 companies in Medical Devices and Diagnostics
  • HTFL ranked among 248 companies in Medical Devices and Diagnostics
  • QDEL ranked among 248 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodBFLYHTFLQDELSPY
1 month -28.3%+10.3%+30.8% -2.0%
3 months -27.4%+99.4%-19.9% -2.2%
6 months +32.8%+81.6%+20.8% +4.2%
Year to date +68.4%+86.6%-50.7% +10.6%
1 year +119.9%+59.8%-49.2% +10.4%
3 years +471.4%—-78.1% +73.6%
3 years, per year +78.9%—-39.7% +20.2%
5 years -38.8%—-89.7% +61.6%
5 years, per year -9.4%—-36.5% +10.1%
10 years ——-24.0% +261.3%
10 years, per year ——-2.7% +13.7%

Risk

MeasureBFLYHTFLQDELSPY
Volatility, 1Y 112.7%76.7%93.2% 12.8%
Downside volatility, 1Y 94.2%77.6%100.8% 12.8%
Beta vs S&P 500, 1Y 3.091.912.58 1.00
Return / volatility, 1Y 1.060.78-0.53 0.81
Max drawdown, 5Y -93.3%-48.7%-94.3% -25.4%
From 52-week high -35.6%-10.1%-60.2% -3.2%
52-week high $9.94$60.53$35.38 $779.14
52-week low $1.97$20.49$9.96 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleBFLYHTFLQDEL
P/E now vs peer median -31.2xmedian 28.1x -39.7xmedian 28.1x -0.9xmedian 28.1x
P/S now vs peer median 12.8xmedian 2.9x 22.2xmedian 2.9x -4.5xmedian 2.9x
EV/EBITDA now vs peer median -28.5xmedian 18.0x -61.0xmedian 18.0x —median 18.0x
P/FCF now vs peer median -57.1xmedian 24.8x -79.7xmedian 24.8x -4.6xmedian 24.8x
P/B now vs peer median 8.5xmedian 2.3x 16.9xmedian 2.3x 0.5xmedian 2.3x
PEG now vs peer median -1.04median 0.95 —median 0.95 0.01median 0.95

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsBFLYHTFLQDEL
Revenue $123.25M $212.08M -$211.90M
Gross profit $86.60M $169.83M –
Operating income -$57.83M -$80.25M –
Net income -$53.69M -$118.37M -$1.05B
Free cash flow -$27.55M -$59.18M -$211.20M
R&D $39.57M $83.84M –
EPS (diluted) $-0.20 $-1.37 $-15.35
Cash & equivalents $122.30M $34.36M $123.40M
Total debt – – $2.89B
Shares (diluted) 262.10M 86.40M 68.30M
Enterprise value $1.25B $4.65B $438.84M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricBFLYHTFLQDEL
P/E -31.2x -39.7x -0.9x
P/FCF -57.1x -79.7x -4.6x
P/Operating cash flow -67.3x -90.3x -16.8x
P/S 12.8x 22.2x -4.5x
P/B 8.5x 16.9x 0.5x
P/Tangible book 8.8x 16.9x -1.1x
EV/EBITDA -28.5x -61.0x –
EV/EBIT -25.1x -55.7x –
EV/Revenue 11.8x 21.1x -17.6x
EV/FCF -52.7x -75.5x -17.7x
EV/Operating cash flow -62.0x -85.6x -65.2x
PEG (3Y EPS CAGR) -1.04 – 0.01

Growth

14 metrics
MetricBFLYHTFLQDEL
Revenue growth (1Y) 39.4% 42.8% -30.8%
Revenue CAGR (3Y) 21.7% – -27.0%
Gross profit growth (1Y) 126.4% 51.8% –
Gross profit CAGR (3Y) 30.5% – –
Operating income growth (1Y) 33.5% -29.0% –
Operating income CAGR (3Y) 26.9% – –
Net income growth (1Y) 32.8% -26.4% -124.8%
Net income CAGR (3Y) 24.2% – -107.7%
EPS growth (1Y) 35.4% 90.8% -122.8%
EPS CAGR (3Y) 30.0% – -106.5%
Operating cash flow growth (1Y) 5.8% 19.4% -128.5%
Operating cash flow CAGR (3Y) 41.1% – -27.1%
Free cash flow growth (1Y) -0.1% 13.0% -1,725%
Free cash flow CAGR (3Y) 38.8% – -30.1%

Profitability

14 metrics
MetricBFLYHTFLQDEL
Gross margin 70.3% 80.1% –
EBITDA margin -41.4% -34.6% –
Operating margin -46.9% -37.8% –
Pretax margin -43.5% -55.9% –
Net margin -43.6% -55.8% –
FCF margin -22.4% -27.9% –
Operating cash flow margin -19.0% -24.6% 27.0%
Return on equity -28.7% -41.9% –
Return on assets -18.8% -34.4% –
Return on invested capital – – –
Return on capital employed -26.6% -26.7% –
Asset turnover 0.4x 0.6x 0.0x
Cash conversion (OCF / net income) 0.4x 0.4x 0.1x
Stock comp / revenue 20.8% 11.2% -20.9%

Financial Health

11 metrics
MetricBFLYHTFLQDEL
Debt / assets – – 50.6%
Debt / equity – – 1.6x
Net debt / EBITDA – – –
Debt / FCF – – -13.7x
Liabilities / assets 36.0% 18.8% 68.9%
Equity / assets 64.0% 81.2% 31.1%
Interest coverage -46.8x -23.2x –
Current ratio 3.6x 5.1x 1.4x
Quick ratio 2.3x 6.6x 0.5x
Cash ratio 1.8x 5.6x 0.1x
Altman Z-score 5.16 39.60 –

Shareholder Returns

7 metrics
MetricBFLYHTFLQDEL
Dividend yield – – –
Net buyback yield -0.5% -7.3% -0.5%
Shareholder yield -0.5% -7.3% -0.5%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusBFLYHTFLQDEL
Forward P/E – – 18.8xFY2026
EPS, next fiscal year $-0.10FY2026 $-0.43FY2026 $0.75FY2026
EPS growth, next FY – – -64.6%FY2026
EPS growth, the year after – – +101.3%
Revenue, next fiscal year $114.50MFY2026 $261.38MFY2026 $2.67BFY2026
Revenue growth, next FY +17.3%FY2026 +48.5%FY2026 -2.0%FY2026
Revenue growth, the year after +26.0% +20.6% +0.2%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersBFLYHTFLQDEL
Held by institutions 59.9% 100.0% 100.0%
Institutions holding 248 193 243
Change in shares held, QoQ +13.9% +133.0% +2.9%
Institutions buying 144 140 143
Institutions selling 59 38 65
Buyers to sellers 2.44 3.68 2.20

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

BFLYHTFLQDEL
BFLY 1.00 0.28 0.24
HTFL 0.28 1.00 0.16
QDEL 0.24 0.16 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, BFLY, HTFL and QDEL?

Heartflow (HTFL) is the largest by market capitalisation: Butterfly Network (BFLY) $1.78B, Heartflow (HTFL) $4.90B, QuidelOrtho (QDEL) $970.54M.

Which company is growing faster?

Heartflow (HTFL) grew revenue fastest over the trailing twelve months: Butterfly Network (BFLY) +39.4%, Heartflow (HTFL) +42.8%, QuidelOrtho (QDEL) -30.8%.

Which company is more profitable?

Butterfly Network (BFLY) has the highest net margin (Butterfly Network (BFLY) -43.6%, Heartflow (HTFL) -55.8%).

Which stock has performed better?

Over the past year Butterfly Network (BFLY) returned the most: Butterfly Network (BFLY) +119.9%, Heartflow (HTFL) +59.8%, QuidelOrtho (QDEL) -49.2%. Over five years, Butterfly Network (BFLY) compounded fastest (Butterfly Network (BFLY) -9.4%/yr, QuidelOrtho (QDEL) -36.5%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Heartflow (HTFL) has been the steadiest (Butterfly Network (BFLY) 112.7%, Heartflow (HTFL) 76.7%, QuidelOrtho (QDEL) 93.2%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, BFLY, HTFL and QDEL?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Butterfly Network (BFLY) leads on 4. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.